Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Rifapentine or Rifampicin with TMC207 in Healthy Subjects
NCT02216331Phase 1Completed
- Sponsor
- TB Alliance
- Start
- Mar 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bedaquiline in Tuberculosis (TB) (2 arms), sponsored by TB Alliance. Primary endpoints: Maximum observed TMC207 concentration, Area under the TMC207 concentration-time curve from time zero to time t and 1 more. Started Mar 2010; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02216331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216331.